<?xml version="1.0" encoding="UTF-8"?>
<!-- generator="wordpress.com" -->
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd"
	xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
	xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
	xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"
	>
<url><loc>https://blog.lifesciencenation.com/2026/05/05/hot-investor-mandate-pre-seed-focused-impact-driven-early-stage-vc-invests-in-neurotech-and-deeptech-with-focus-in-usa/</loc><news:news><news:publication><news:name>Next Phase Newsletter</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-05T16:21:59+00:00</news:publication_date><news:title>Hot Investor Mandate: Pre-Seed Focused Impact-Driven Early Stage VC Invests in Neurotech and Deeptech With Focus in USA </news:title><news:keywords>technology, health, business, entrepreneurship, finance, investing</news:keywords></news:news></url><url><loc>https://blog.lifesciencenation.com/2026/05/05/hot-investor-mandate-multi-family-office-firm-invests-in-companies-and-aligned-funds-in-biotech-precision-medicine-and-medtech/</loc><news:news><news:publication><news:name>Next Phase Newsletter</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-05T16:21:41+00:00</news:publication_date><news:title>Hot Investor Mandate: Multi-Family Office Firm Invests in Companies and Aligned Funds in Biotech, Precision Medicine, and Medtech  </news:title><news:keywords>technology, health, business, entrepreneurship, finance, investing</news:keywords></news:news></url><url><loc>https://blog.lifesciencenation.com/2026/05/05/hot-investor-mandate-asia-based-healthcare-focused-vc-invests-broadly-in-all-life-science-sectors-actively-making-cross-border-investments/</loc><news:news><news:publication><news:name>Next Phase Newsletter</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-05T16:21:24+00:00</news:publication_date><news:title>Hot Investor Mandate: Asia-Based Healthcare-Focused VC Invests Broadly in All Life Science Sectors, Actively Making Cross-Border Investments </news:title><news:keywords>technology, health, business, entrepreneurship, finance, investing</news:keywords></news:news></url><url><loc>https://blog.lifesciencenation.com/2026/05/05/hot-investor-mandate-global-multi-stage-life-sciences-investor-seeks-therapies-addressing-high-unmet-medical-need-in-north-america-and-asia/</loc><news:news><news:publication><news:name>Next Phase Newsletter</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-05T16:21:05+00:00</news:publication_date><news:title>Hot Investor Mandate: Global Multi-Stage Life Sciences Investor Seeks Therapies Addressing High Unmet Medical Need in North America and Asia</news:title><news:keywords>technology, health, business, entrepreneurship, finance, investing</news:keywords></news:news></url><url><loc>https://blog.lifesciencenation.com/2026/05/05/oncovita-a-novel-measles-based-approach-to-unlock-immunotherapy-in-solid-tumors/</loc><news:news><news:publication><news:name>Next Phase Newsletter</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-05T12:31:22+00:00</news:publication_date><news:title>Oncovita: A Novel Measles-Based Approach to Unlock Immunotherapy in Solid Tumors</news:title><news:keywords>venture capital, science, entrepreneur, technology, startups, marketing, health, business, entrepreneurship, finance, cancer, writing, digital-marketing, education, immunotherapy, social-media, dailyprompt</news:keywords></news:news></url><url><loc>https://blog.lifesciencenation.com/2026/05/05/convention-week-how-to-get-the-most-investor-inlicensor-meetings-exposure/</loc><news:news><news:publication><news:name>Next Phase Newsletter</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-05T12:15:26+00:00</news:publication_date><news:title>Convention Week: How to Get the Most Investor/Inlicensor Meetings &#038; Exposure </news:title><news:keywords>venture capital, Research, technology, startups, travel, AI, business, entrepreneurship, finance, investing, art, writing, books, economy, politics, history, education, religion, economics, photography</news:keywords></news:news></url><url><loc>https://blog.lifesciencenation.com/2026/05/05/from-viability-to-capital-financing-risk/</loc><news:news><news:publication><news:name>Next Phase Newsletter</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-05T12:05:23+00:00</news:publication_date><news:title>From Viability to Capital: Financing Risk </news:title><news:keywords>venture capital, Healthcare, news, science, technology, startups, marketing, health, AI, business, entrepreneurship, finance, investing, artificial-intelligence, digital-marketing, leadership, chatgpt, sustainability</news:keywords></news:news></url></urlset>